Effect of topical beta APN application on evoked potential conduction in rat sciatic nerve and spinal cord.
The purpose of this study is to evaluate possible toxic effects of beta-aminopropionitrile fumarate (beta APN), a lathyrogenic agent that inhibits fibrosis. This drug has been considered for use as an adjunct to surgical repair after topical application upon peripheral and central nervous system structures. In vivo and in vitro studies were done using rats to study the dose dependent neurotoxicity of this water soluble chemical. The results indicate that when the neural sheaths are removed the amplitude of the evoked sciatic nerve potential is irreversibly suppressed from 1 to 10 mM concentrations of beta APN. Nerve conduction velocities are relatively less affected with reduction from 43 to 35 m/sec by beta APN immersion. Similarly, the spinal cord studies show that when the dura and arachnoid are opened and damaged, 0.1 mM beta APN causes increased latency (from 9.9 to 14.5 msec) and decreased amplitude (from 79.4 to 56.8 microV) of cortical somatosensory evoked potentials. Possible mechanisms for the neurotoxic effects of beta APN are discussed.
D000629:Aminopropionitrile / Q000031:analogs & derivatives* / Q000633:toxicity; D000818:Animals; D004305:Dose-Response Relationship, Drug; D005073:Evoked Potentials, Somatosensory / Q000187:drug effects*; D009431:Neural Conduction / Q000187:drug effects; D051381:Rats; D011919:Rats, Inbred Strains; D012584:Sciatic Nerve / Q000187:drug effects*; D013116:Spinal Cord / Q000187:drug effects*
C027243:beta-aminopropionitrile fumarate; D000629:Aminopropionitrile